Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

AMBS Laying the Groundwork for an Up-Listing


we are focused on taking key fundamental value-building steps to advance LymPro towards commercialization, projected for the second half of 2014. We are also reprioritizing our pipeline for MANF as new data is gathered in various orphan indications and planning the critical path to first-in-man studies. As we move these programs forward, the funds raised gives the Company the necessary resources to attract the key management talent necessary to actualize these plans and further lend credibility to our programs by having proven teams executing them. As data continues to flow in, we believe we will be in a position to fundamentally improve shareholder value in the coming months and ultimately put the Company in a position to up-list to a national exchange.

http://www.thechairmansblog.com/gerald-commissiong/2013-09/financial-stability-heading-into-2014-laying-the-groundwork-for-an-up-listing.html